What do we know about India’s Covaxin vaccine?-Reference-Cited by-同舟云学术

What do we know about India’s Covaxin vaccine?

Published:2021-04-20 Issue: Volume: Page:n997
ISSN:1756-1833
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Thiagarajan Kamala

Publisher

BMJ

Subject

General Engineering

Reference17 articles.

1. Bharat Biotech . https://www.bharatbiotech.com/exports.html

2. Kay C. ‘Sometimes I get goosebumps,’ says Bharat Biotech MD as firm preparing for Covaxin rollout. Bloomberg 2020. https://www.livemint.com/science/health/indian-covid-vaccine-maker-bharat-biotech-readies-for-covaxin-rollout-11608625913405.html

3. What do we know about China’s covid-19 vaccines?

4. Robertson S. India's whole-virion inactivated SARS-CoV-2 vaccine shows promise. News Medical Life Sciences 2020. https://www.news-medical.net/news/20200913/Indias-whole-virion-inactivated-SARS-CoV-2-vaccine-shows-promise.aspx

5. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development;Virology Journal;2024-04-26

2. Acceptance and Attitudes towards Covid-19 Vaccines: A Cross-Sectional Study from India;Biosciences Biotechnology Research Asia;2023-12-31

3. ANCA-associated vasculitis with systemic thrombotic microangiopathy: A review of literature;Indian Journal of Nephrology;2023-10-23

4. Challenges and opportunities for India on the world stage;The Lancet;2023-09

5. An interpreter ranking index-based MCDM technique for COVID-19 treatments under a bipolar fuzzy environment;Results in Control and Optimization;2023-09